Q3 FY21 results and investor call takeaways - Sun Pharma - YES Securities

- Revs up 3% qoq and 8% yoy while margins at 27% came ahead of estimate of 26%

- Ex Taro US sales came in stronger than expected at USD235mn Vs estimate USD 215mn.

- India sales came in robust at 9% yoy Vs expected 5%

- Margin at 27% aided by decline in other expenses and flat staff costs qoq.

- R&D higher at Rs5.6bn Vs Rs5.3bn a year ago.

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.586.45 as compared to the previous close of Rs. 564.4. The total number of shares traded during the day was 944430 in over 25167 trades.

The stock hit an intraday high of Rs. 599.9 and intraday low of 554.05. The net turnover during the day was Rs. 545798187.

Source : Equity Bulls

Keywords